"技术引进后的时间点适用

[出版论文]

“Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study“
(Ye et al., International Immunopharmacology. (2024) 130. 111706)

发表海报

[学会发表]

“Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YH35324, a Novel Long-Acting High-Affinity IgEtrap-Fc Fusion protein, in Atopic Subjects with a Total IgE > 700 IU/mL”
发表海报 (2024 AAAAI)

发表海报

[学会发表]

“Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation to Predict Efficacious Human Doses for YH35324(GI-301)”
发表海报 (2023 ASCPT)

发表海报

[学会发表]

“Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YH35324, a Novel Long-Acting High-Affinity IgEtrap-Fc protein in Subjects with Atopy: Results from the First-in-Human Study”
发表海报 (2023 EAACI)

发表海报

[学会发表]

“Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation to Predict Efficacious Human Doses for YH35324(GI-301)”
发表海报 (2023 PAGE)

发表海报